Thank you for taking the time to view this webinar, we hope you find it informative

RCPath CPD accredited

Co-presenters: Dr Kordo Saaed – Southampton, David Partridge – Sheffield
Chaired by: Dr Jonathan Sandoe – Leeds

– – – – –

If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.

Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.

If you have any problems creating or downloading your certificate please contact Esme Carruthers at ecarruthers@bsac.org.uk

 

This webinar is supported by an educational grant from Thermofisher.

Speakers/Presenters

• 

  Dr Jonathan Sandoe, Associate Professor of Microbiology
  

  Dr Jonathan Sandoe is Associate Professor of Medical Microbiology at the University of Leeds and Honorary Consultant Microbiologist at Leeds Teaching Hospitals NHS Trust. Clinical and research interests include management of infective endocarditis, healthcare associated infections and antimicrobial stewardship, from behaviour change to clinical trials. He currently leads the NIHR-funded PEACH study Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients.

• 

  Dr Kordo Saeed, Consultant clinical microbiologist
  

  Consultant clinical microbiologist at University of Southampton Medical School. He is passionate about infection prevention & control, antibiotic stewardship and management of bone and joint infections.

• 

  Dr David Partridge, Consultant Microbiologist
  

  David Partridge is a Consultant Microbiologist and Infection Control Doctor at Sheffield Teaching Hospitals and Honorary Senior Lecturer at the Florey Institute, University of Sheffield. He has an interest in infections of the immunocompromised host and device related infection. During the COVID-19 pandemic, he has been working on clinical utility of sequencing of SARS-CoV-2 and also on management of secondary infections.